Seres Therapeutics (MCRB) EBT Margin (2016 - 2026)
Seres Therapeutics (MCRB) recorded EBT Margin of -2865.76% in Q2 2026, up 2883.40 percentage points from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) EBT Margin (2016 - 2026) Analysis & Trends
On a TTM basis, Seres Therapeutics' EBT Margin came in at -4379.45% as of Jun 30, 2026; for FY2025, it was -11627.88%.
- Annual EBT Margin has a five-year change of -11356.60 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -2565.60% in FY2022 (-2521.07 pp) and -44.53% in FY2021 (+226.76 pp).
- The Q2 2026 figure is the highest quarterly EBT Margin since Q2 2023.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 5336.60 percentage points in Q2 2023, against a drop of 11811.64 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -5749.16% (Q1 2026), -4322.37% (Q4 2025) and -6227.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -4.34% |
| 10 | Seres Therapeutics | 20.53 Mn | -118.30 Mn | - | -2,865.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,865.76% |
| Mar 31, 2026 | -5,749.16% |
| Dec 31, 2025 | -4,322.37% |
| Sep 30, 2025 | -6,227.64% |
| Sep 30, 2023 | -13,552.90% |
| Jun 30, 2023 | 38.00% |
| Mar 31, 2023 | -13,694.25% |
| Dec 31, 2022 | -225.33% |
| Sep 30, 2022 | -1,741.26% |
| Jun 30, 2022 | -5,298.60% |
| Mar 31, 2022 | -3,769.52% |
| Dec 31, 2021 | -688.06% |
| Sep 30, 2021 | 53.86% |
| Jun 30, 2021 | -912.88% |
| Mar 31, 2021 | -613.08% |
| Dec 31, 2020 | -102.73% |
| Sep 30, 2020 | -2,161.26% |
| Jun 30, 2020 | -350.54% |
| Mar 31, 2020 | -247.27% |
| Dec 31, 2019 | -248.01% |
API Access
Seres Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();